Teligent competitorsClear all

Otonomy's top competitors include Shire, Pharnext and Mersana Therapeutics.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Shire
Shire
Shire is a specialty biopharmaceutical company.
Pharnext
Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Mersana Therapeutics
Mersana Therapeutics
Mersana Therapeutics is a clinical stage antibody drug conjugate company.
Founding Date
Founding Date
2008
Founding Date
1986
Founding Date
2007
Founding Date
2005
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Dublin, IE HQ
The Rocks, AU
Wien, AT
Bruxelles, BE
Sofia, BG
see more
Locations
Issy-les-Moulineaux, FR HQ
Locations
Cambridge, US HQ
Employees
Employees
498% decrease
Employees
23,044
Employees
4319% increase
Employees
8610% increase
Valuation ($)
Valuation ($)
73.6 m
Valuation ($)
54.8 b
Valuation ($)
123.1 m
Valuation ($)
203.8 m
Twitter followers
Twitter followers
233
Twitter followers
7.7 k
Twitter followers
796
Twitter followers
706
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
35
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
3.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
318925
Alexa Website Rank
333836
Alexa Website Rank
1335066
Alexa Website Rank
784116

Financial

Revenue (est.)
Revenue (est.)
$745k (FY, 2018)
Revenue (est.)
$15.2b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$25.2m (FY, 2016)
Net income
Net income
($50.4m) (FY, 2018)
Net income
$3.1m (FY, 2017)
Net income
N/A
Net income
($13.7m) (FY, 2016)

Operating

Phase I Trials Products
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Preclinical Phase Products
Preclinical Phase Products
1 (FY, 2016)
Preclinical Phase Products
35 (FY, 2017)
Preclinical Phase Products
N/A
Preclinical Phase Products
N/A

Funding

Total funding raised
Total funding raised
$ 153.4m
Total funding raised
N/A
Total funding raised
$ 10.6m
Total funding raised
$ 219.5m
For sources of this data, please see the company profile

View company profiles

Shire
HQ
Dublin, IE
Employees
23,044

Shire is a specialty biopharmaceutical company.

View company
Pharnext
HQ
Issy-les-Moulineaux, FR
Employees
43↑ 19% increase

Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.

View company
Mersana Therapeutics
HQ
Cambridge, US
Employees
86↑ 10% increase

Mersana Therapeutics is a clinical stage antibody drug conjugate company.

View company